Summary
YKL-40 is a mammalian member of the chitinase protein family. Although the function of YKL-40 is unknown, the pattern of its expression suggests a function in remodelling or degradation of extracellular matrix. High serum YKL-40 has been found in patients with recurrent breast cancer and has been related to short survival. In the present study we analysed YKL-40 in preoperative sera from patients with colorectal cancer and evaluated its relation to survival. Serum YKL-40 was determined by RIA in 603 patients. Survival after operation was registered, and median follow-up time was 61 months. Three hundred and forty patients died. Sixteen per cent of the patients with Dukes’ A, 26% with Dukes’ B, 19% with Dukes’ C and 39% with Dukes’ D had high serum YKL-40 levels (adjusted for age). Analysis of serum YKL-40 as a continuous variable showed an association between increased serum YKL-40 and short survival (P < 0.0001). Patients with high preoperative serum YKL-40 concentration had significantly shorter survival than patients with normal YKL-40 (HR = 1.7; 95% CI: 1.3–2.1, P < 0.0001). Multivariate Cox analysis including serum YKL-40, serum CEA, Dukes’ stage, age and gender showed that high YKL-40 was an independent prognostic variable for short survival (HR = 1.4; 95% CI: 1.1–1.8, P = 0.007). These results suggest that YKL-40 may play an important role in tumour invasion.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bresalier, R. S., Byrd, J. C., Wang, L. & Raz, A. (1996). Colon cancer mucin: a new ligand for the β-galactoside-binding protein galectin-3. Cancer Res, 56: 4354–4357.
Dukes, C. & Bussey, H. J. R. (1958). The spread of rectal cancer and its effect on prognosis. Br J Cancer 12: 309–320.
Finlay, I. & McArdle, C. S. (1983). Effect of occult hepatic metastases on survival after curative resection for colorectal carcinoma. Gastroenterology 85: 596–599.
Hakala, B. E., White, C. & Recklies, A. D. (1993). Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem, 268: 5803–5810.
Hu, B., Trinh, K., Figueira, W. F. & Price, P. A. (1996). Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 271: 19415–19420.
Jass, J. R., Love, S. B. & Northover, J. M. (1987). A new prognostic classification of rectal cancer. Lancet, 1: 1303–1306.
Johansen, J. S., Williamson, M. K., Rice, J. S. & Price, P. A. (1992). Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res, 7: 501–512.
Johansen, J. S., Jensen, H. S. & Price, P. A. (1993). A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol, 32: 949–955.
Johansen, J. S., Cintin, C., Jørgensen, M., Kamby, C. & Price, P. A. (1995). Serum YKL-40: a new potential marker of prognosis and location of metastases of patients with recurrent breast cancer. Eur J Cancer, 31A: 1437–1442.
Johansen, J. S., Hvolris, J., Hansen, M., Backer, V., Lorenzen, I. & Price, P. A. (1996). Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol, 35: 553–559.
Kievit, J. & Van de Velde, C. J. H. (1990). Utility and cost of carcinoembryonic antigen monitoring in colon cancer follow-up evaluation. Cancer, 65: 2580–2587.
Kirkpatrick, R. B., Emery, J. G., Connor, J. R., Dodds, R., Lysko, P. G. & Rosenberg, M. (1997). Induction and expression of human cartilage glycoprotein 39 in rheumatoid inflammatory and peripheral blood monocyte-derived macrophages. Exp Cell Res 237: 46–54.
Krause, S. W., Rehli, M., Kreutz, M., Schwarzfischer, L., Paulauskis, J. D. & Andreesen, R. (1996). Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 60: 540–545.
Lucha, P. A., Rosen, L., Olenwine, J. A., Reed, J. F., Riether, R. D., Stasik, J. J. & Khubchandani, I. T. (1997). Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. Dis Colon Rectum, 40: 145–149.
McArdle, C. S., Hole, D., Hansell, D., Blumgart, L. H. & Wood, C. B. (1990). Prospective study of colorectal cancer in the West of Scotland: 10 year follow-up. Br J Surg, 77: 280–282.
Morrison, B. W. & Leder, P. (1994). neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 9: 3417–3426.
Newland, R. C., Chapuis, P. H. & Smyth, E. J. (1987). The prognostic value of substaging colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer, 60: 852–857.
Nielsen, H. J., McArdle, C. S. & Moesgaard, F. The RANX05 Study Group (1998). The effect of ranitidine on long-term survival in primary colorectal cancer. G I Cancer, 2: 227–233.
Nyirkos, P. & Golds, E. E. (1990). Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J, 268: 265–268.
Raz, A., Zhu, D., Hogan, V., Shah, N., Raz, T., Karkash, R., Pazerine, G. & Carmi, P. (1990). Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. Int J Cancer, 46: 871–877.
Rehli, M., Krause, S. W. & Andreesen, R. (1997). Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics, 43: 221–225.
Renkema, G. H., Boot, G. R., Au, F. L., Donker-Koopman, W. E., Strijland, A., Muijsers, A. O., Hrebicek, M. & Aerts, JMFG (1998). Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem, 251: 504–509.
Royston, P. (1991). Constructing time-specific reference ranges. Statist Med, 10: 675–690.
Shoeppner, H. L., Raz, A., Ho, S. B. & Bresalier, R. S. (1995). Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon. Cancer, 75: 2818–2826.
Shackelton, L. M., Mann, D. M. & Millis, A. J. T. (1995). Identification of a 38-kDa heparin binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem, 270: 13076–13083.
Skjak-Braek, G., Anthonsen, T. & Sandford, P. A. (1989). Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications, Elsevier Applied Science: New York
Ståhle, E., Glimelius, B., Bergstrom, R. & Pahlman, L. (1989). Preoperative prediction of outcome in patients with rectal and rectosigmoid cancer. Cancer, 63: 1831–1837.
Virgo, K. S., Vernava, A. M., Longo, W. E., McKirgan, L. W. & Johnson, F. E. (1995). Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA, 23: 1837–1841.
Volck, B., Price, P. A., Johansen, J. S., Sørensen, O., Benfield, T., Nielsen, H. J., Calafat, J. & Borregaard, N. (1998). YKL-40, a mammalian member of the bacterial chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Phys, 110: 351–360.
Wiggers, T., Arends, J. W., Schutte, B. & Volovics Bosman, F. T. (1988). A multivariate analysis of pathological prognostic indicators in large bowel cancer. Cancer, 61: 386–395.
Wojciechowitcz, D. C., Park, P. Y. & Baty, P. B. (1995). β1–6 branching of N-linked carbohydrate is associated with K-ras mutation in human colon carcinoma cell lines. Biochem Biophys Res Commun, 212: 758–766.
Author information
Authors and Affiliations
Additional information
*YKL-40 has been named after its molecular weight (40 kDa) and the one letter code for its three N-terminal amino acids (Johansen et al, 1992). The protein is also called human cartilage glycoprotein-39 (HC gp-39) (Hakala et al, 1993)
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Cintin, C., Johansen, J., Christensen, I. et al. Serum YKL-40 and colorectal cancer. Br J Cancer 79, 1494–1499 (1999). https://doi.org/10.1038/sj.bjc.6690238
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690238
Keywords
- carcinoembryonic antigen
- colorectal cancer
- metastasis
- tumour invasiveness
- YKL-40/HC gp-39
This article is cited by
-
YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models
Cellular Oncology (2021)
-
Dysregulation of cancer genes by recurrent intergenic fusions
Genome Biology (2020)
-
Chitinase-3 like-protein-1 function and its role in diseases
Signal Transduction and Targeted Therapy (2020)
-
Prognostic value of YKL-40 in solid tumors: a meta-analysis of 41 cohort studies
Cancer Cell International (2019)
-
Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?
Tumor Biology (2016)
